These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 23428664)

  • 21. Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: effectiveness of an injection protocol based on the vascular anatomy of the nose.
    Dheyauldeen S; Østertun Geirdal A; Osnes T; Vartdal LS; Dollner R
    Laryngoscope; 2012 Jun; 122(6):1210-4. PubMed ID: 22565282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Rendu-Osler disease: clinical and molecular update].
    Bailly S; Dupuis-Girod S; Plauchu H
    Med Sci (Paris); 2010 Oct; 26(10):855-60. PubMed ID: 20929677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells.
    Albiñana V; Bernabeu-Herrero ME; Zarrabeitia R; Bernabéu C; Botella LM
    Thromb Haemost; 2010 Mar; 103(3):525-34. PubMed ID: 20135064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mosaic ACVRL1 and ENG mutations in hereditary haemorrhagic telangiectasia patients.
    Best DH; Vaughn C; McDonald J; Damjanovich K; Runo JR; Chibuk JM; Bayrak-Toydemir P
    J Med Genet; 2011 May; 48(5):358-60. PubMed ID: 21378382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular diagnosis in hereditary hemorrhagic telangiectasia: findings in a series tested simultaneously by sequencing and deletion/duplication analysis.
    McDonald J; Damjanovich K; Millson A; Wooderchak W; Chibuk JM; Stevenson DA; Gedge F; Bayrak-Toydemir P
    Clin Genet; 2011 Apr; 79(4):335-44. PubMed ID: 21158752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hereditary haemorrhagic telangiectasia in North African and sub-Saharan patients.
    Canzonieri C; Ornati F; Matti E; Chu F; Manfredi G; Olivieri C; Buscarini E; Pagella F
    S Afr Med J; 2014 Apr; 104(4):256-7. PubMed ID: 25118534
    [No Abstract]   [Full Text] [Related]  

  • 27. Detection of a significant association between mutations in the ACVRL1 gene and hepatic involvement in German patients with hereditary haemorrhagic telangiectasia.
    Brakensiek K; Frye-Boukhriss H; Mälzer M; Abramowicz M; Bahr MJ; von Beckerath N; Bergmann C; Caselitz M; Holinski-Feder E; Muschke P; Oexle K; Strobl-Wildemann G; Wolff G; El-Harith EA; Stuhrmann M
    Clin Genet; 2008 Aug; 74(2):171-7. PubMed ID: 18498373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bevacizumab as a treatment for hereditary hemorrhagic telangiectasia in children: a case report.
    Ospina FE; Echeverri A; Posso-Osorio I; Jaimes L; Gutierrez J; Tobón GJ
    Colomb Med (Cali); 2017 Jun; 48(2):88-93. PubMed ID: 29021642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prevalence of hereditary hemorrhagic telangiectasia in juvenile polyposis syndrome.
    O'Malley M; LaGuardia L; Kalady MF; Parambil J; Heald B; Eng C; Church J; Burke CA
    Dis Colon Rectum; 2012 Aug; 55(8):886-92. PubMed ID: 22810475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pulmonary hypertension in hereditary haemorrhagic teleangiectasia].
    Reichenberger F; Wehner LE; Breithecker A; Voswinckel R; Mensch O; Schulz R; Ghofrani HA
    Pneumologie; 2009 Nov; 63(11):669-74. PubMed ID: 19790036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output.
    Dupuis-Girod S; Ginon I; Saurin JC; Marion D; Guillot E; Decullier E; Roux A; Carette MF; Gilbert-Dussardier B; Hatron PY; Lacombe P; Lorcerie B; Rivière S; Corre R; Giraud S; Bailly S; Paintaud G; Ternant D; Valette PJ; Plauchu H; Faure F
    JAMA; 2012 Mar; 307(9):948-55. PubMed ID: 22396517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Re-treating bleeding hereditary haemorrhagic telangiectasia with bevacizumab.
    Ho GY; Zhong E; Chern B
    Med J Aust; 2013 Nov; 199(10):658. PubMed ID: 24237088
    [No Abstract]   [Full Text] [Related]  

  • 33. More on bevacizumab in hereditary hemorrhagic telangiectasia.
    Oosting S; Nagengast W; de Vries E
    N Engl J Med; 2009 Aug; 361(9):931; author reply 931-2. PubMed ID: 19710496
    [No Abstract]   [Full Text] [Related]  

  • 34. Hereditary hemorrhagic telangiectasia/avastin.
    Davidson TM; Olitsky SE; Wei JL
    Laryngoscope; 2010 Feb; 120(2):432-5. PubMed ID: 19998344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bevacizumab in the treatment of hereditary hemorrhagic telangiectasia.
    Kanellopoulou T; Alexopoulou A
    Expert Opin Biol Ther; 2013 Sep; 13(9):1315-23. PubMed ID: 23815519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose - response relationship of bevacizumab in hereditary hemorrhagic telangiectasia.
    Azzopardi N; Dupuis-Girod S; Ternant D; Fargeton AE; Ginon I; Faure F; Decullier E; Roux A; Carette MF; Gilbert-Dussardier B; Hatron PY; Lacombe P; Leguy-Seguin V; Rivière S; Corre R; Bailly S; Paintaud G
    MAbs; 2015; 7(3):630-7. PubMed ID: 25751241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. More on bevacizumab in hereditary hemorrhagic telangiectasia.
    Retornaz F; Rinaldi Y; Duvoux C
    N Engl J Med; 2009 Aug; 361(9):931; author reply 931-2. PubMed ID: 19714790
    [No Abstract]   [Full Text] [Related]  

  • 38. Distribution of ENG and ACVRL1 (ALK1) mutations in French HHT patients.
    Lesca G; Burnichon N; Raux G; Tosi M; Pinson S; Marion MJ; Babin E; Gilbert-Dussardier B; Rivière S; Goizet C; Faivre L; Plauchu H; Frébourg T; Calender A; Giraud S;
    Hum Mutat; 2006 Jun; 27(6):598. PubMed ID: 16705692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DHPLC-based mutation analysis of ENG and ALK-1 genes in HHT Italian population.
    Lenato GM; Lastella P; Di Giacomo MC; Resta N; Suppressa P; Pasculli G; Sabbà C; Guanti G
    Hum Mutat; 2006 Feb; 27(2):213-4. PubMed ID: 16429404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hereditary haemorrhagic telangiectasia: From symptomatic management to pathogenesis based treatment.
    Fernández-Fernández FJ
    Eur J Hum Genet; 2010 Apr; 18(4):404; author reply. PubMed ID: 19888298
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.